Balversa 5 MG tablet 28S
Ended Awarded
- Contract number
- SPE2DB25FJB14
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,060
Award facts
- Contract value 100% obligated
- $18,059.57 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $18,059.57 delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Balversa 5 mg tablets (28-count units). This is a firm fixed price, competitively awarded contract with no set-aside designation, scheduled for completion by August 14, 2025. The contract is performed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child delivery order, this award falls under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999 pharmaceutical prime vendor agreement running through December 2026.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency's medical supply chain. The company's extensive contract portfolio with DLA encompasses a broad range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. This delivery order for Balversa, an oncology medication, represents a typical transaction within AmerisourceBergen's established relationship as a pharmaceutical prime vendor supplying the Department of Defense's healthcare infrastructure.
Quick answers
Who was awarded contract SPE2DB25FJB14?
SPE2DB25FJB14 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 24, 2025.
How much is contract SPE2DB25FJB14 worth?
The government has obligated $18,060 on SPE2DB25FJB14.
Is contract SPE2DB25FJB14 an order under another contract?
Yes. SPE2DB25FJB14 is a delivery order under SPE2DB22D2206, an indefinite delivery contract.
Was contract SPE2DB25FJB14 competed?
The extent of competition for SPE2DB25FJB14 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award